Frank Holler's most recent trade in Xenon Pharmaceuticals Inc was a trade of 36,008 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 27, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 36,008 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 27 May 2021 | 36,008 | 160,628 (0%) | 0% | 3.8 | 135,390 | Common Shares |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Sale of securities on an exchange or to another person at price $ 18.68 per share. | 27 May 2021 | 8,485 | 143,653 (0%) | 0% | 18.7 | 158,500 | Common Shares |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 27 May 2021 | 5,911 | 154,717 (0%) | 0% | 18.9 | 111,600 | Common Shares |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2021 | 3,086 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 27 May 2021 | 3,086 | 125,127 (0%) | 0% | 3.8 | 11,603 | Common Shares |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 27 May 2021 | 2,579 | 152,138 (0%) | 0% | 18.7 | 48,202 | Common Shares |
| Xenon Pharmaceuticals Inc | Frank Holler | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 27 May 2021 | 507 | 124,620 (0%) | 0% | 18.9 | 9,572 | Common Shares |